Question to the Department for Business and Trade:

To ask the Secretary of State for Business and Trade, which Department is responsible for monitoring of pharmaceutical provisions within the UK-US Economic Prosperity Deal; and whether he plans to update Parliament on those provisions.

DBT Secretary of State made a written statement to Parliament on 2 December.

This deal is the first and only agreement with the US that secures zero percent tariffs on pharmaceutical products – the lowest rate offered to any country. It delivers mitigations on the US’ ‘Most Favoured Nation’ policy and preferential terms for UK medtech exports – helping expand access to innovative treatments for patients and driving crucial investment in the UK.

The Department for Business and Trade remains the lead department for EPD negotiations.

There will be further work to finalise underpinning details.